1.	Phase II Pilot Combination Chemotherapy with MVP (MITO/VBL/CACP) and Piroxicam for Disseminated non-Small Cell Carcinoma of the Lung Phase: Phase II Type: Treatment Status: Closed Age: no age specified Sponsor: NCI Protocol IDs: EST-PD-983, EST-P-D983
2.	Phase II Study of Autolymphocyte Therapy for the Treatment of Cancer for Which There is No Conventional Therapy Available (Summary Last Modified 10/88) Phase: Phase II Type: Treatment Status: Closed Age: over 18 Sponsor: Protocol IDs: BUMC-CT-2, NCI-V88-0411
3.	Phase II Immunotherapy with Alpha-2 IFN plus Immunoregulation with Feldene in Patients with Disseminated Malignant Melanoma (Summary Last Modified 03/89) Phase: Phase II Type: Treatment Status: Closed Age: any age Sponsor: NCI Protocol IDs: EST-PZ-686, EST-P-Z686
4.	Phase IIb Randomized Cancer Prevention Study of the Effects of Piroxicam on Colon Mucosa Phase: Phase II Type: Prevention Status: Closed Age: 40 to 80 Sponsor: Protocol IDs: UARIZ-CA41108-06, NCI-P92-0009
5.	Phase I Randomized Chemoprevention Study of PXM, DFMO, and PXM/DFMO in Patients with Previously Treated Skin Cancer, Stage I Prostate or Breast Cancer, Dukes' A Colon Cancer, and Subjects with a Family History of These Tumors (Summary Last Modified 06/96) Phase: Phase I Type: Prevention Status: Closed Age: 21 and over Sponsor: Other Protocol IDs: WCCC-CO-9134, NCI-P92-0022